These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 19459168

  • 1. Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.
    Horsdal HT, Johnsen SP, Søndergaard F, Jacobsen J, Thomsen RW, Schmitz O, Sørensen HT, Rungby J.
    Diabetes Metab Res Rev; 2009 Sep; 25(6):515-22. PubMed ID: 19459168
    [Abstract] [Full Text] [Related]

  • 2. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
    Horsdal HT, Mehnert F, Rungby J, Johnsen SP.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
    [Abstract] [Full Text] [Related]

  • 3. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C.
    Circulation; 2008 Apr 15; 117(15):1945-54. PubMed ID: 18378618
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study.
    Horsdal HT, Johnsen SP, Søndergaard F, Rungby J.
    Diabetologia; 2008 Apr 15; 51(4):567-74. PubMed ID: 18283428
    [Abstract] [Full Text] [Related]

  • 6. Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007.
    Walker AM, Koro CE, Landon J.
    Pharmacoepidemiol Drug Saf; 2008 Aug 15; 17(8):760-8. PubMed ID: 18383443
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials.
    Yap YG, Duong T, Bland JM, Malik M, Torp-Pederson C, Køber L, Connolly SJ, Gallagher MM, Camm AJ.
    J Hypertens; 2007 Feb 15; 25(2):307-13. PubMed ID: 17211237
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ, Deifuss S, Klamann A, Schmiegel W, Nauck MA, LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Exp Clin Endocrinol Diabetes; 2003 Sep 15; 111(6):344-50. PubMed ID: 14520601
    [Abstract] [Full Text] [Related]

  • 10. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.
    Schramm TK, Gislason GH, Vaag A, Rasmussen JN, Folke F, Hansen ML, Fosbøl EL, Køber L, Norgaard ML, Madsen M, Hansen PR, Torp-Pedersen C.
    Eur Heart J; 2011 Aug 15; 32(15):1900-8. PubMed ID: 21471135
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension.
    Jonas M, Reicher-Reiss H, Boyko V, Behar S, Grossman E.
    J Hum Hypertens; 2003 Oct 15; 17(10):665-70. PubMed ID: 14504623
    [Abstract] [Full Text] [Related]

  • 13. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
    Nilsson PM, Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Fagard R, Gudbjörnsdóttir S, Swedish National Diabetes Register.
    Eur J Cardiovasc Prev Rehabil; 2009 Aug 15; 16(4):506-12. PubMed ID: 19561510
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.
    Sakabe K, Fukuda N, Fukuda Y, Wakayama K, Nada T, Morishita S, Shinohara H, Tamura Y.
    Nutr Metab Cardiovasc Dis; 2008 Feb 15; 18(2):121-6. PubMed ID: 17346952
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metabolic syndrome and risk of cardiovascular events after myocardial infarction.
    Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R, GISSI-Prevenzione Investigators.
    J Am Coll Cardiol; 2005 Jul 19; 46(2):277-83. PubMed ID: 16022955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.